🧬 The future of DNA synthesis is here. We are proud to announce the launch of our 𝟱𝟬 𝗸𝗯 𝗖𝗹𝗼𝗻𝗮𝗹 𝗗𝗡𝗔 — the 𝗹𝗼𝗻𝗴𝗲𝘀𝘁 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗲-𝗽𝗲𝗿𝗳𝗲𝗰𝘁 𝘀𝘆𝗻𝘁𝗵𝗲𝘁𝗶𝗰 𝗗𝗡𝗔 ever made commercially available. Built on Ansa’s proprietary 𝗲𝗻𝘇𝘆𝗺𝗮𝘁𝗶𝗰 𝘀𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘀 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺, this breakthrough product delivers 𝗳𝘂𝗹𝗹𝘆 𝘃𝗲𝗿𝗶𝗳𝗶𝗲𝗱 𝟱𝟬 𝗸𝗯 𝗰𝗼𝗻𝘀𝘁𝗿𝘂𝗰𝘁𝘀 𝗶𝗻 𝗹𝗲𝘀𝘀 𝘁𝗵𝗮𝗻 𝟮𝟱 𝗱𝗮𝘆𝘀. And it’s backed by the 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆’𝘀 𝗼𝗻𝗹𝘆 𝗢𝗻-𝗧𝗶𝗺𝗲 𝗚𝘂𝗮𝗿𝗮𝗻𝘁𝗲𝗲. No more assembly. No more long lead times. Just long, error-free DNA — delivered fast and guaranteed. 👉 Read the press release: https://hubs.li/Q03PJ3PD0 #DNAsynthesis #SynBio #Innovation #GeneSynthesis
Ansa Biotechnologies, Inc.
Biotechnology Research
Emeryville, California 9,943 followers
High-fidelity DNA synthesis using enzymes
About us
At Ansa Biotechnologies, we’re developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our technology empowers scientists to develop solutions for the world's biggest problems in health and sustainability. Note that Ansa does not conduct any employment discussions via LinkedIn. All official Ansa career openings are exclusively listed on our website careers page.
- Website
-
http://www.ansabio.com
External link for Ansa Biotechnologies, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Emeryville, California
- Type
- Privately Held
- Founded
- 2018
- Specialties
- DNA
Locations
-
Primary
Get directions
1198 65th St
Suite 250
Emeryville, California 94608, US
Employees at Ansa Biotechnologies, Inc.
-
Scott Kosch
Private Investor | AI Transformation Educator | Board Director and Mentor to CEOs | Advisor to PE and VC firms | Transhumanist
-
Jason T. Gammack
Chief Executive Officer at Ansa Biotechnologies
-
Bethany Dalton Hoover
Global E2E Business Operations Leader | Commercial & Supply Chain Operations
-
Evan King
Life Sciences Commercial | Strategic Accounts; Pharma, Clinical Trials, CRO
Updates
-
Ansa Biotechnologies, Inc. reposted this
🧬 Finding the right vector just got easier — and faster. Announcing Ansa’s new Catalog Vectors! Choose from a variety of options for 𝗰𝗹𝗼𝗻𝗶𝗻𝗴, 𝗯𝗮𝗰𝘁𝗲𝗿𝗶𝗮𝗹, 𝗺𝗮𝗺𝗺𝗮𝗹𝗶𝗮𝗻, 𝗔𝗔𝗩, 𝗮𝗻𝗱 𝘁𝗿𝗮𝗻𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻 𝗮𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 — all available directly in our eCommerce portal. And you can skip the upfront postage and paperwork. Simply upload your sequence file, select your vector, and Ansa will ship your completed DNA to you. Looking for something more tailored? We also offer an early access program for Custom Vector onboarding. 🔗 Explore the new Catalog Vectors: https://hubs.li/Q03MlWRh0
-
-
🧬 Finding the right vector just got easier — and faster. Announcing Ansa’s new Catalog Vectors! Choose from a variety of options for 𝗰𝗹𝗼𝗻𝗶𝗻𝗴, 𝗯𝗮𝗰𝘁𝗲𝗿𝗶𝗮𝗹, 𝗺𝗮𝗺𝗺𝗮𝗹𝗶𝗮𝗻, 𝗔𝗔𝗩, 𝗮𝗻𝗱 𝘁𝗿𝗮𝗻𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻 𝗮𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 — all available directly in our eCommerce portal. And you can skip the upfront postage and paperwork. Simply upload your sequence file, select your vector, and Ansa will ship your completed DNA to you. Looking for something more tailored? We also offer an early access program for Custom Vector onboarding. 🔗 Explore the new Catalog Vectors: https://hubs.li/Q03MlWRh0
-
-
Securing $54.4M in Series B funding is more than a milestone — it’s fuel for our mission to expand what’s possible for scientists. In his latest article, CEO Jason T. Gammack shares how Ansa is preparing for the next stage of growth and what it means for our customers. 🔗 Read more: https://lnkd.in/gUwwTSV4
We said we’d change DNA synthesis. One year later, we did. $54.4M in Series B means we’re just getting started. The next chapter is simple: make the impossible routine. I would like to express my gratitude to the investors who supported both the bold idea and its execution, to the Ansa team whose grit and drive made this possible, and to our customers who trusted a young company to deliver what the legacy players couldn’t (and still can’t). Innovation only counts if it empowers scientists. In year one, we unlocked sequence space that the old guard couldn’t access, enabled applications once considered impossible, and proved that reliability isn’t optional; it’s guaranteed. Our mission is to tear down every barrier between you and the DNA your research demands. No more caps imposed by outdated providers. We’re scientists building for scientists, and every bit of our focus is on enabling you to accomplish more. Year one of commercialization proved the point: ✅ We redefined what’s possible in gene synthesis, shipping sequences scientists had never been able to access. ✅ We shattered the length and complexity ceiling, delivering constructs up to 50kb, sequence agnostic, in timelines that make “impossible” look routine. ✅ We had the audacity to guarantee it by launching the Ansa On-Time Guarantee. If we don’t deliver on the promised date, your entire order is free. Meanwhile, the legacy shops just deliver excuses. ✅ We ditched the black-box pricing games of other vendors and replaced them with value-based pricing: the lowest cost per base in the industry for straightforward constructs, scaling logically with length and complexity. Legacy vendors are trapped in the past, serving up delays and excuses as if that’s acceptable. We’re not playing that game. Ansa is leading a new way: DNA that’s longer, cleaner, guaranteed, and delivered when promised, so scientists can finally advance their ideas without hitting a wall. Year one was the warm-up. The real game starts now. Ansa Biotechnologies. Expect more. https://lnkd.in/e2XPNauB #GeneSynthesis #GoBigOrGoHome #AnsaOnTimeGuarantee #SynBio #DNAsynthesis #GenomeBuilders #GratefulCEO #NotYourGrandfathersSynthesisCompany
-
🚀 $54.4M Series B Secured 🚀 We’re excited to share that we’ve closed an oversubscribed round to help us scale our U.S.-based manufacturing, advance new products, and deliver the first-of-its-kind guarantee for the industry: DNA shipped on time or it’s free. Led by Cerberus Ventures alongside top-tier investors, this funding will make both standard and complex DNA synthesis more accessible, enabling scientists to expand their design space and push the boundaries of discovery. 👉 Read the Press Release: https://hubs.li/Q03LHnJs0
-
-
#DYK: Ansa provides two flexible formats to help accelerate your research potential? Ansa offers complex DNA sequences in both sequence-perfect clonal DNA or sequence-verified linear double-stranded DNA fragment formats. Our 𝗔𝗻𝘀𝗮 𝗖𝗹𝗼𝗻𝗮𝗹 𝗗𝗡𝗔 and 𝗔𝗻𝘀𝗮 𝗗𝗡𝗔 𝗙𝗿𝗮𝗴𝗺𝗲𝗻𝘁𝘀 are easy to integrate into your experimental workflows, with up-front pricing and guaranteed delivery times. ➡️ Learn more: https://lnkd.in/dA9CvyQ6 #DNAsynthesis #AnsaOnTime #DNAGuaranteed #NoDelaysJustDNA #SynthesisWithoutStress
-
-
💪 𝗖𝗼𝗻𝗾𝘂𝗲𝗿 𝗖𝗼𝗺𝗽𝗹𝗲𝘅 𝗦𝗲𝗾𝘂𝗲𝗻𝗰𝗲𝘀 Don't shy away from challenging elements like hairpins, repeats, or high/low GC content. Our advanced technology is designed to handle the complexity of naturally occurring DNA, allowing you to study the biology you want, without compromise. 🧬 https://lnkd.in/edkBEzEs #DNAsynthesis #longDNA #SyntheticDNA #DNAInnovation #customDNA
-
-
At Touchlight, reliable, on-time enzymatic DNA delivery isn't just a bonus, it's 𝘮𝘪𝘴𝘴𝘪𝘰𝘯 𝘤𝘳𝘪𝘵𝘪𝘤𝘢𝘭. If vendors fail, research stalls, manufacturing slots are lost, and reputations are on the line. 🎧 Hear from Alex Cotton, PhD, about how working with Ansa has given his team the ability to plan their projects with confidence, and how crucial it is to companies providing services to scientists. ➡️ Learn more about how Ansa is committed to robust, routine delivery, backed by the industry’s only 𝗢𝗻-𝗧𝗶𝗺𝗲 𝗚𝘂𝗮𝗿𝗮𝗻𝘁𝗲𝗲: https://lnkd.in/g7jZ2Enh #DNAsynthesis #SynthesisWithoutStress #biotech #AnsaOnTime #NoDelaysJustDNA #SyntheticDNA
-
𝗕𝗲𝘀𝘁 𝗗𝗡𝗔. 𝗕𝗲𝘀𝘁 𝗣𝗿𝗶𝗰𝗲. 𝗡𝗼 𝗖𝗼𝗺𝗽𝗿𝗼𝗺𝗶𝘀𝗲. Announcing Clonal DNA starting at $𝟬.𝟭𝟯/𝗯𝗽. Backed by the industry’s only On-Time Guarantee, Ansa delivers the standard and complex builds you need with the accuracy science demands. ✅ 𝗖𝗹𝗼𝗻𝗮𝗹 𝗗𝗡𝗔 𝘀𝘁𝗮𝗿𝘁𝗶𝗻𝗴 𝗮𝘁 $𝟬.𝟭𝟯/𝗯𝗽 ✅ 𝗖𝗼𝗻𝘀𝘁𝗿𝘂𝗰𝘁𝘀 𝗳𝗿𝗼𝗺 𝟮𝟬𝟬 𝗯𝗽 𝘁𝗼 𝟱𝟬 𝗸𝗯 ✅ 𝗧𝘂𝗿𝗻𝗮𝗿𝗼𝘂𝗻𝗱 𝘁𝗶𝗺𝗲𝘀 𝗯𝗲𝗴𝗶𝗻𝗻𝗶𝗻𝗴 𝗮𝘁 𝗷𝘂𝘀𝘁 𝟲 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗱𝗮𝘆𝘀 ✅ 𝗔𝗻𝘀𝗮 𝗢𝗻-𝗧𝗶𝗺𝗲 𝗚𝘂𝗮𝗿𝗮𝗻𝘁𝗲𝗲 This isn’t just a price drop. It is rewriting what’s possible in DNA synthesis. See the new pricing: https://lnkd.in/e9gnV-xa #DNAsynthesis #SyntheticDNA #AnsaOnTime #NoDelaysJustDNA #SynthesisWithoutStress